MTRX31
Asset
Restores mitochondrial health by rebalancing fat and carbohydrate oxidation toward carbohydrate oxidation.
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- Oxidative phosphorylation
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Metabolically unhealthy obesity
Preclinical, mitorxtherapeutics.com, 10 Oct 2026
Obesity
Preclinical, mitorxtherapeutics.com, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Evidence for its targets2
- Competitors12
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.